Document is current
Any future updates will be listed below
-
Authors
Nieweglowska, Eliza S. https://orcid.org/0000-0002-9204-3002
Brilot, Axel F. https://orcid.org/0000-0001-8548-4224
Méndez-Moran, Melissa https://orcid.org/0000-0003-0817-7292
Kokontis, Claire
Baek, Minkyung https://orcid.org/0000-0003-3414-9404
Li, Junrui
Cheng, Yifan https://orcid.org/0000-0001-9535-0369
Baker, David https://orcid.org/0000-0001-7896-6217
Bondy-Denomy, Joseph https://orcid.org/0000-0002-4909-9481
Agard, David A. https://orcid.org/0000-0003-3512-695X
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM140847, R01GM127489, R35GM118099)
U.S. Department of Health & Human Services | NIH | NIH Office of the Director (1S10OD020054, 1S10OD026881)
U.S. Department of Health & Human Services | NIH | NIH Office of the Director
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI171041)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
- License Information
-
More Information
Article History
Received: 6 April 2022
Accepted: 3 February 2023
First Online: 18 February 2023
Competing interests
: J.B.-D. is a scientific advisory board member of SNIPR Biome, Excision Biotherapeutics, and LeapFrog Bio, as well as a scientific advisory board member and co-founder of Acrigen Biosciences. The Bondy-Denomy lab receives research support from Felix Biotechnology. The remaining authors declare no competing interests.
